Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma
about
Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytesCyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapyCOX-2: Where are we in 2003? - Specific cyclooxygenase-2 inhibitors and aspirin-exacerbated respiratory diseaseUpdate on the Management of Aspirin-Exacerbated Respiratory DiseaseAspirin-exacerbated respiratory disease: pathophysiological insights and clinical advancesThe leukotriene C(4) synthase gene and asthmaMultiple NSAID intolerance in chronic idiopathic urticaria is correlated with delayed, pronounced and prolonged autoreactivityPolymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approachAspirin-sensitive asthmaCOX-1 sparing drugs in aspirin-sensitive asthmaSafety of a specific COX-2 inhibitor in aspirin-induced asthmaSerum interleukin-5 in aspirin-induced asthmaAn open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthmaEmerging role of antileukotriene therapy in allergic rhinitisImprovement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trialA new insight into aspirin-induced asthmaThe role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitorsComplement C3a and C4a increased in plasma of patients with aspirin-induced asthmaLack of association of glutathione S-transferase P1 Ile105Val polymorphism with aspirin-intolerant asthmaIncreased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthmaAsthma, nasal polyposis and ulcerative colitis: a new perspectiveProtection against exercise-induced bronchoconstriction by montelukast in aspirin-sensitive and aspirin-tolerant patients with asthmaA comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin-intolerant asthmaBronchial mast cells are the dominating LTC4S-expressing cells in aspirin-tolerant asthma6-Shogaol reduced chronic inflammatory response in the knees of rats treated with complete Freund's adjuvantG-protein-coupled receptors and asthma endophenotypes: the cysteinyl leukotriene system in perspectiveBiological effects of leukotriene E4 on eosinophilsCysteinyl leukotrienes and their receptors; emerging conceptsAntileukotrienes in upper airway inflammatory diseasesAlleviating Promotion of Inflammation and Cancer Induced by Nonsteroidal Anti-Inflammatory DrugsAspirin-exacerbated respiratory disease: Prevalence, diagnosis, treatment, and considerations for the futureEosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease.Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease.Chronic Rhinosinusitis: More Than Just "Asthma of the Upper Airway"Factors driving the aspirin exacerbated respiratory disease phenotype.Cysteinyl leukotrienes in chronic hyperplastic rhinosinusitis.Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory diseaseProminent role of IFN-γ in patients with aspirin-exacerbated respiratory disease.Interleukin-4 in the Generation of the AERD Phenotype: Implications for Molecular Mechanisms Driving Therapeutic Benefit of Aspirin Desensitization.Leukotriene Inhibitors in Sinusitis.
P2860
Q24633568-DD9E3E45-1ECC-4FBF-AD75-513EF03082C8Q24675327-33D1F9E3-4D74-48B8-9748-57176D6B1ED2Q24796213-546A2406-A524-4531-BB1A-3B87A1CB4C01Q26749097-2237FF9D-6020-4C51-8E06-5A3E88E47507Q26750424-CBB06252-EC59-4187-9D03-FAA44557C33AQ28145246-9C3DF764-CC7D-4E84-B07A-1D3B4CC4E081Q28168891-54D22253-8EFD-4917-9B91-A96DED910FD4Q28171243-32B7611B-09A4-4051-BAB5-60BEF78FDC46Q28174122-98D977D1-A170-43F3-9132-2517DEB031FFQ28177176-B194F7F0-04A0-486C-BC56-6AB4747CE71BQ28177184-0A019B1C-60FC-472C-8FF7-8D07B10F3DC9Q28186724-08FDDB46-8963-4C21-A793-82CB248507B2Q28189893-1D79DB16-9B82-4715-B575-503713E13248Q28191844-39C826E9-0379-4DCB-B9B7-224E00D71628Q28192038-AEBCD946-148B-429B-963F-AFBDCB8A7854Q28192535-5FFBD7AD-7D69-4630-B9FC-A2533CC479A7Q28192716-785E99E9-3D10-4F80-8032-F2A20E3A05BCQ28193417-45D41264-B499-4157-B9DD-6CBB20E5CCF5Q28193443-6272AA22-920C-444A-9991-903AD4C665FCQ28193535-D9C4868C-CD8D-47DA-B730-B77C49458A34Q28193641-EC748617-A92D-4F4F-8351-ED0262F6AE6DQ28193713-D8D7D064-380B-4059-A78A-370F451EFF8FQ28193908-89FD2AEE-87DA-4F40-9CF4-0D3A6AE6BC73Q28196491-B3BFD25F-D324-4370-B31B-6F92079F4AB4Q28200582-C7F47B92-048F-490D-AABD-67E07ECFECE5Q28212087-B1E7B2D8-F4E8-4A05-A93D-FA31F791F740Q28238927-792FE845-6085-404B-9377-CC2A447C563CQ28243252-0CDA7EDE-4836-4F51-8D3D-8EE8DC549F4EQ28267571-271AD144-822C-49A4-929F-C084106C2E56Q30234292-969BB850-168D-4747-AD9E-F2F4CD846DC4Q30238776-2C4E22DD-9CEF-43E3-B1FE-012EB042DFCEQ30275780-EDBDA617-AA50-47DB-8312-D9E714F51C3CQ30276354-20DD8195-D94F-44A4-9062-86E51E8192E4Q30278686-D0FB10F4-ADB8-4394-B824-88DC8FE4D768Q30300955-2956E171-63DF-4D68-95F5-A81B2F82D196Q30310359-44B0B2E6-B9C9-4994-A98F-FE7A84B8ED43Q30384450-66C4C774-A8F1-4AB2-A534-13CD6CFB870AQ30410446-4EB8A417-1B57-4962-8109-90E6D493DCEBQ30428747-CDD4CE45-641F-4A71-A787-EBB977DF8A48Q30455019-4B7E46E8-57F3-490D-BEA1-069E6D5E3013
P2860
Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma
description
1998 nî lūn-bûn
@nan
1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Overexpression of leukotriene ...... with aspirin-intolerant asthma
@ast
Overexpression of leukotriene ...... with aspirin-intolerant asthma
@en
Overexpression of leukotriene ...... with aspirin-intolerant asthma
@nl
type
label
Overexpression of leukotriene ...... with aspirin-intolerant asthma
@ast
Overexpression of leukotriene ...... with aspirin-intolerant asthma
@en
Overexpression of leukotriene ...... with aspirin-intolerant asthma
@nl
prefLabel
Overexpression of leukotriene ...... with aspirin-intolerant asthma
@ast
Overexpression of leukotriene ...... with aspirin-intolerant asthma
@en
Overexpression of leukotriene ...... with aspirin-intolerant asthma
@nl
P2093
P2860
P921
P3181
P356
P1476
Overexpression of leukotriene ...... with aspirin-intolerant asthma
@en
P2093
A P Sampson
A S Cowburn
E Nizankowska
F K Austen
J F Penrose
P2860
P304
P3181
P356
10.1172/JCI620
P407
P577
1998-02-15T00:00:00Z